Blokhin Cancer Research Center (Moscow, Russia)

Sites / RUS

Blokhin Cancer Research Center (Moscow, Russia)

RUS · PI Dr. Moreau · activated

KRI 0.299

Patients

7

Active

0

Serious AEs

3

Open QA

0

Aged queries

8

Luna users

0

Studies & contracts

1

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Phase II · study completed · 102000 USD

executed

Patients

7

P2B-012

completed

P2B-018

completed

P2B-082

completed

P2B-118

completed

P2B-127

completed

P2B-128

screened

P2B-130

completed

Safety

33 AEs · 3 serious

Grade 3 anaemia with onset in cycle 4 (2013-10-17); serious (hospitalization); assessed as related to study drug (probable); resolved 2013-11-10; action: drug interrupted.

serious P2B-130

Grade 3 diarrhoea with onset in cycle 3 (2012-09-22); serious (hospitalization); assessed as related to study drug (possible); resolved 2012-09-24; action: drug interrupted.

serious P2B-018

Grade 3 febrile neutropenia with onset in cycle 1 (2012-07-15); serious (hospitalization); assessed as related to study drug (probable); resolved 2012-07-23; action: dose reduced.

serious P2B-012

QA findings

0 open

VISIT OUT OF WINDOW: Cycle Day 1 visit outside the +/-3-day window without a documented toxicity delay (subject P2B-012, 2012-08-23)

resolved minor

Visits & payments

0

Nothing scheduled. Re-score risk to let the pipeline propose a visit.

Luna participants

0

No Luna participants here yet. Participants join once invited by the site.

Open Luna